EUVIMEDEUVIMED entdecken
Open Access

Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma–GATA3 molecular subgroup

Waseem G Lone iD, Jiayu Yu, Xuxiang Liu iD, Dylan T Jochum iD, Alyssa Bouska iD, Kunal Shetty iD, Tyler Herek, Sunandini Sharma, Chengfeng Bi iD, Rauf Shah iD, Zaina W Nasser, Catalina Amador iD und 20 weitere

Science Advances · 2025

DOI: 10.1126/sciadv.adx6877 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Waseem G Lone und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, NE, USA. Hauptthemen laut MEDLINE: GATA3 Transcription Factor, Tumor Suppressor Protein p53, PTEN Phosphohydrolase, Lymphoma, T-Cell, Peripheral. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peripheral T cell lymphoma (PTCL) is a heterogeneous group of postthymic T cell neoplasms, with ~40% classified as PTCL–not otherwise specified (PTCL-NOS). PTCL-GATA3, a molecularly defined subtype, associated with T helper 2 (T H 2)–like differentiation and poor prognosis, has frequent co-occurrence of TP53 loss/mutation and heterozygous PTEN loss. CD4+ T cell conditional mouse models with Trp53 mutation/deletion and Pten loss demonstrated mature T cell lymphomas (mTCLs) with T H 2-like transcriptomic and immunophenotypic profiles. Molecular studies revealed that codeletion of Trp53/Pten induced T cell receptor and Janus kinase–signal transducer and activator of transcription signaling, promoting T H 2 differentiation while inhibiting T H 1 differentiation. These findings were validated by CRISPR editing of TP53/PTEN loss in human CD4+ T cells and mechanistically evaluated the p53 binding region in intron-3 of GATA3, resulting in transcriptional repression. Transcriptomic profiles of m-TCLs recapitulated human-PTCL-GATA3 transcriptome and distinguished PTCL-NOS subtypes. Preclinical assessment of m-TCLs with PI3Kγ/δ inhibitors significantly improved survival, supporting a therapeutic approach for the p53-aberrant PTCL-GATA3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GATA3 Transcription FactorTumor Suppressor Protein p53PTEN PhosphohydrolaseLymphoma, T-Cell, PeripheralAnimalsHumansMiceGene Expression Regulation, NeoplasticMutationCD4-Positive T-Lymphocytes

Substanzen

GATA3 Transcription FactorTumor Suppressor Protein p53PTEN PhosphohydrolaseGATA3 protein, humanTP53 protein, humanPTEN protein, human

Autor:innen und Institutionen

  • Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, NE, USA.
  • Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA.
  • Division of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
  • Department of Pathology, University of Miami, Miami, FL, USA.
  • Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Department of Biology, University of Nebraska at Omaha, Omaha, NE, USA.

ORCID-Profile: Waseem G Lone, Xuxiang Liu, Dylan T Jochum, Alyssa Bouska, Kunal Shetty, Chengfeng Bi, Rauf Shah, Catalina Amador, Abdul Rouf Mir, R Katherine Hyde, Mamiko Sakata-Yanagimoto, Satyanarayana Rachagani, Timothy W McKeithan, David W Scott, Louis M Staudt, Andrew Feldman, Timothy Greiner, Julie M Vose, Joesph Khoury, Wing C Chan, Javeed Iqbal

Förderung

  • NCI NIH HHS

Zitieren

APA

Lone, W. G., Yu, J., Liu, X., Jochum, D. T., Bouska, A., Shetty, K., Herek, T., Sharma, S., Bi, C., Shah, R., Nasser, Z. W., Amador, C., Arif, A., Mir, A. R., Li, Y., Heavican-Foral, T. B., Robinson, J., Hyde, R. K., Sakata-Yanagimoto, M., …, & Lymphoma/Leukemia Molecular Profiling Project (LLMPP) (2025). Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma–GATA3 molecular subgroup. Science Advances. https://doi.org/10.1126/sciadv.adx6877

Vancouver

Lone WG, Yu J, Liu X, Jochum DT, Bouska A, Shetty K, et al. Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma–GATA3 molecular subgroup. Science Advances. 2025. doi:10.1126/sciadv.adx6877

BibTeX
@article{Lone2025,
  author = {Lone, Waseem G and Yu, Jiayu and Liu, Xuxiang and Jochum, Dylan T and Bouska, Alyssa and Shetty, Kunal and Herek, Tyler and Sharma, Sunandini and Bi, Chengfeng and Shah, Rauf and Nasser, Zaina W and Amador, Catalina and Arif, Aiza and Mir, Abdul Rouf and Li, Yuping and Heavican-Foral, Tayla B and Robinson, Jacob and Hyde, R Katherine and Sakata-Yanagimoto, Mamiko and Rachagani, Satyanarayana and McKeithan, Timothy W and Scott, David W and Staudt, Louis M and Inghirami, Giorgio and Feldman, Andrew and Greiner, Timothy and Vose, Julie M and Rimsza, Lisa and Khoury, Joesph and Chan, Wing C and Iqbal, Javeed and Lymphoma/Leukemia Molecular Profiling Project (LLMPP), Lymphoma/Leukemia Molecular Profiling Project (LLMPP)},
  title = {Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma–GATA3 molecular subgroup},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adx6877}
}
Kostenlos starten →